+
+
Over 90% of preventable deaths occur in developing countries
yet these countries receive less than 10% of health research funding
The Pharmaceutical Industry Has A Race Problem
+
DRUG DEVELOPMENT FOLLOWS THE MONEY, NOT THE NEED.
DISEASES AFFECTING COMMUNITIES OF THE GLOBAL SOUTH GET UNDERFUNDED WHILE COMPARABLE CONDITIONS IN THE GLOBAL NORTH ATTRACT BILLIONS.
THE RESULT IS A TWO-TIERED SYSTEM WHERE YOUR RACE DETERMINES YOUR ACCESS TO LIFESAVING TREATMENTS.
This Disease Is Not Profitable
+
SICKLE CELL DISEASE IS A LIFE-THREATENING ILLNESS WITH DEBILITATING SYMPTOMS THAT PRIMARILY AFFECTS POOR BLACK AND BROWN COMMUNITIES.
IT RECEIVES LESS RESEARCH, FEWER CLINICAL TRIALS, AND DELAYED TREATMENTS, NOT BECAUSE SOLUTIONS DON’T EXIST, BUT BECAUSE PROFIT COMES FIRST.
+ WATCH AND SEE WHO PAYS WHEN RESEARCH FOLLOWS PROFIT
ALL BLOOD IS RED
ALL BLOOD IS RED
+
THE FACTS
Black Health Is Being Starved By Pharmaceutical Neglect
FACT 1
WHILE BILLIONS POUR INTO RESEARCH FOR CONDITIONS THAT AFFECT RICHER COMMUNITIES, GENETIC CONDITIONS LIKE SICKLE CELL DISEASE ARE SYSTEMICALLY UNDERFUNDED AND OVERLOOKED.
FACT 2
SICKLE CELL DISEASE IS THE MOST COMMON MONOGENIC HEREDITARY DISEASE ... WITH MORE THAN 300,000 NEW PATIENTS EVERY YEAR GLOBALLY.
FACT 3
LIFE EXPECTANCY OF SICKLE CELL DISEASE PATIENTS IS REDUCED BY MORE THAN 20 YEARS.
FACT 4
MOST CASES ARE IN SUB-SAHARAN AFRICA AND INDIA.
